Literature DB >> 27495120

A Quantitative Review and Meta-Models of the Variability and Factors Affecting Oral Drug Absorption-Part I: Gastrointestinal pH.

Ahmad Y Abuhelwa1, David J R Foster2, Richard N Upton2.   

Abstract

This study aimed to conduct a quantitative meta-analysis for the values of, and variability in, gastrointestinal (GI) pH in the different GI segments; characterize the effect of food on the values and variability in these parameters; and present quantitative meta-models of distributions of GI pH to help inform models of oral drug absorption. The literature was systemically reviewed for the values of, and the variability in, GI pH under fed and fasted conditions. The GI tract was categorized into the following 10 distinct regions: stomach (proximal, mid-distal), duodenum (proximal, mid-distal), jejunum and ileum (proximal, mid, and distal small intestine), and colon (ascending, transverse, and descending colon). Meta-analysis used the "metafor" package of the R language. The time course of postprandial stomach pH was modeled using NONMEM. Food significantly influenced the estimated meta-mean stomach and duodenal pH but had no significant influence on small intestinal and colonic pH. The time course of postprandial pH was described using an exponential model. Increased meal caloric content increased the extent and duration of postprandial gastric pH buffering. The different parts of the small intestine had significantly different pH. Colonic pH was significantly different for descending but not for ascending and transverse colon. Knowledge of GI pH is important for the formulation design of the pH-dependent dosage forms and in understanding the dissolution and absorption of orally administered drugs. The meta-models of GI pH may also be used as part of semi-physiological pharmacokinetic models to characterize the effect of GI pH on the in vivo drug release and pharmacokinetics.

Entities:  

Keywords:  fed state pH; gastric pH; gastrointestinal pH; meal caloric content; meta-analysis

Mesh:

Substances:

Year:  2016        PMID: 27495120     DOI: 10.1208/s12248-016-9952-8

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  36 in total

1.  Inflammation does not decrease intraluminal pH in chronic inflammatory bowel disease.

Authors:  K Ewe; S Schwartz; S Petersen; A G Press
Journal:  Dig Dis Sci       Date:  1999-07       Impact factor: 3.199

2.  Characterization of the human upper gastrointestinal contents under conditions simulating bioavailability/bioequivalence studies.

Authors:  Lida Kalantzi; Konstantinos Goumas; Vasilios Kalioras; Bertil Abrahamsson; Jennifer B Dressman; Christos Reppas
Journal:  Pharm Res       Date:  2006-12-01       Impact factor: 4.200

3.  pH-profile and regional transit times of the normal gut measured by a radiotelemetry device.

Authors:  J Fallingborg; L A Christensen; M Ingeman-Nielsen; B A Jacobsen; K Abildgaard; H H Rasmussen
Journal:  Aliment Pharmacol Ther       Date:  1989-12       Impact factor: 8.171

4.  Measurement of gastrointestinal pH profiles in normal ambulant human subjects.

Authors:  D F Evans; G Pye; R Bramley; A G Clark; T J Dyson; J D Hardcastle
Journal:  Gut       Date:  1988-08       Impact factor: 23.059

5.  Duodenal pH values in normal controls and in patients with duodenal ulcer.

Authors:  S J Rune; K Viskum
Journal:  Gut       Date:  1969-07       Impact factor: 23.059

6.  Upper gastrointestinal (GI) pH in young, healthy men and women.

Authors:  J B Dressman; R R Berardi; L C Dermentzoglou; T L Russell; S P Schmaltz; J L Barnett; K M Jarvenpaa
Journal:  Pharm Res       Date:  1990-07       Impact factor: 4.200

7.  Effect of diet on gastric secretion.

Authors:  F P Brooks
Journal:  Am J Clin Nutr       Date:  1985-11       Impact factor: 7.045

8.  Investigation of pH and Temperature Profiles in the GI Tract of Fasted Human Subjects Using the Intellicap(®) System.

Authors:  Mirko Koziolek; Michael Grimm; Dieter Becker; Ventzeslav Iordanov; Hans Zou; Jeff Shimizu; Christoph Wanke; Grzegorz Garbacz; Werner Weitschies
Journal:  J Pharm Sci       Date:  2014-11-19       Impact factor: 3.534

9.  Effects of lactulose and other laxatives on ileal and colonic pH as measured by a radiotelemetry device.

Authors:  R L Bown; J A Gibson; G E Sladen; B Hicks; A M Dawson
Journal:  Gut       Date:  1974-12       Impact factor: 23.059

10.  Changes in parietal cell structure and function in HIV disease.

Authors:  G Lake-Bakaar; M Elsakr; N Hagag; S Lyubsky; J Ahuja; B Craddock; R T Steigbigel
Journal:  Dig Dis Sci       Date:  1996-07       Impact factor: 3.199

View more
  12 in total

1.  Gastrointestinal synthetic epithelial linings.

Authors:  Junwei Li; Thomas Wang; Ameya R Kirtane; Yunhua Shi; Alexis Jones; Zaina Moussa; Aaron Lopes; Joy Collins; Siddartha M Tamang; Kaitlyn Hess; Rameen Shakur; Paramesh Karandikar; Jung Seung Lee; Hen-Wei Huang; Alison Hayward; Giovanni Traverso
Journal:  Sci Transl Med       Date:  2020-08-26       Impact factor: 17.956

2.  Mechanistic Assessment of the Effect of Omeprazole on the In Vivo Pharmacokinetics of Itraconazole in Healthy Volunteers.

Authors:  Ahmad Y Abuhelwa; Stuart Mudge; Richard N Upton; David J R Foster
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2019-04       Impact factor: 2.441

3.  Investigation of the Uptake and Transport of Aspirin Eugenol Ester in the Caco-2 Cell Model.

Authors:  Qi Tao; Zhe Qin; Xi-Wang Liu; Zhen-Dong Zhang; Shi-Hong Li; Li-Xia Bai; Jian-Yong Li; Ya-Jun Yang
Journal:  Front Pharmacol       Date:  2022-05-04       Impact factor: 5.988

4.  Population in vitro-in vivo pharmacokinetic model of first-pass metabolism: itraconazole and hydroxy-itraconazole.

Authors:  Ahmad Y Abuhelwa; Stuart Mudge; Richard N Upton; David J R Foster
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-11-17       Impact factor: 2.745

5.  An Atlas of β-Glucuronidases in the Human Intestinal Microbiome.

Authors:  Rebecca M Pollet; Emma H D'Agostino; William G Walton; Yongmei Xu; Michael S Little; Kristen A Biernat; Samuel J Pellock; Loraine M Patterson; Benjamin C Creekmore; Hanna N Isenberg; Rohini R Bahethi; Aadra P Bhatt; Jian Liu; Raad Z Gharaibeh; Matthew R Redinbo
Journal:  Structure       Date:  2017-06-01       Impact factor: 5.006

6.  Structure, function, and inhibition of drug reactivating human gut microbial β-glucuronidases.

Authors:  Kristen A Biernat; Samuel J Pellock; Aadra P Bhatt; Marissa M Bivins; William G Walton; Bich Ngoc T Tran; Lianjie Wei; Michael C Snider; Andrew P Cesmat; Ashutosh Tripathy; Dorothy A Erie; Matthew R Redinbo
Journal:  Sci Rep       Date:  2019-01-29       Impact factor: 4.379

7.  A Whole-Body Physiologically Based Pharmacokinetic Model Characterizing Interplay of OCTs and MATEs in Intestine, Liver and Kidney to Predict Drug-Drug Interactions of Metformin with Perpetrators.

Authors:  Yiting Yang; Zexin Zhang; Ping Li; Weimin Kong; Xiaodong Liu; Li Liu
Journal:  Pharmaceutics       Date:  2021-05-11       Impact factor: 6.321

Review 8.  Dihydromyricetin: A review on identification and quantification methods, biological activities, chemical stability, metabolism and approaches to enhance its bioavailability.

Authors:  Dan Liu; Yiqin Mao; Lijun Ding; Xin-An Zeng
Journal:  Trends Food Sci Technol       Date:  2019-07-25       Impact factor: 12.563

9.  Processing of Polyvinyl Acetate Phthalate in Hot-Melt Extrusion-Preparation of Amorphous Solid Dispersions.

Authors:  Marius Monschke; Kevin Kayser; Karl G Wagner
Journal:  Pharmaceutics       Date:  2020-04-09       Impact factor: 6.321

10.  Ontogeny Related Changes in the Pediatric Liver Metabolome.

Authors:  Christopher M Wilson; Qian Li; Roger Gaedigk; Charlie Bi; Saskia N de Wildt; J Steven Leeder; Brooke L Fridley
Journal:  Front Pediatr       Date:  2020-09-29       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.